Aura Biosciences, Inc. (AURA) NASDAQ
6.54
-0.16(-2.39%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.54
-0.16(-2.39%)
Currency In USD
| Market Cap | 328.84M |
| Enterprise Value | 286.7M |
| P/E Ratio | -3.72 |
| PEG Ratio | -0.4 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.88 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.63 |
| Return On Equity | -0.71 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -111.66M |
| Net Income | -106.19M |
| Diluted EPS | -1.76 |
| Total Cash | 144.24M |
| Total Cash/Share | 2.39 |
| Total Debt | 17.38M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 8.15 |
| Book Value Per Share | 2.27 |
| 52-Week Change | 14.54 |
| 52-Week High | 7.48 |
| 52-Week Low | 4.35 |
| Moving Average 50 Days | 5.9 |
| Moving Average 200 Days | 6.09 |
| Average Volume | 232,850 |
| Shares Outstanding | 63.5M |
| % Held by Institutions | 76.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |